217 related articles for article (PubMed ID: 2422270)
1. Delineation and characterization of human B cell subpopulations at various stages of activation by using a B cell-specific monoclonal antibody.
Kikutani H; Nakamura H; Sato R; Kimura R; Yamasaki K; Hardy RR; Kishimoto T
J Immunol; 1986 Jun; 136(11):4027-34. PubMed ID: 2422270
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of an early activation marker restricted to human B cells.
Kikutani H; Kimura R; Nakamura H; Sato R; Muraguchi A; Kawamura N; Hardy RR; Kishimoto T
J Immunol; 1986 Jun; 136(11):4019-26. PubMed ID: 3084651
[TBL] [Abstract][Full Text] [Related]
3. Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA.
Thompson CB; Scher I; Schaefer ME; Lindsten T; Finkelman FD; Mond JJ
J Immunol; 1984 Nov; 133(5):2333-42. PubMed ID: 6207226
[TBL] [Abstract][Full Text] [Related]
4. Production of BSF-1 during an in vivo, T-dependent immune response.
Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
[TBL] [Abstract][Full Text] [Related]
5. Human peripheral blood B lymphocyte subpopulations: functional and phenotypic analysis of surface IgD positive and negative subsets.
Jelinek DF; Splawski JB; Lipsky PE
J Immunol; 1986 Jan; 136(1):83-92. PubMed ID: 3484392
[TBL] [Abstract][Full Text] [Related]
6. IgM- and IgD-bearing peripheral blood lymphocytes differentiate to IgM but not IgG or IgA immunoglobulin-secreting cells.
Saiki O; Ralph P
Eur J Immunol; 1982 Jun; 12(6):506-10. PubMed ID: 6981514
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.
Goroff DK; Stall A; Mond JJ; Finkelman FD
J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432
[TBL] [Abstract][Full Text] [Related]
8. Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation.
Nakagawa T; Nakagawa N; Goldstein H; Volkman DJ; Fauci AS
J Immunol; 1986 Nov; 137(10):3175-82. PubMed ID: 2945860
[TBL] [Abstract][Full Text] [Related]
9. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
[TBL] [Abstract][Full Text] [Related]
10. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody.
Boyd AW; Anderson KC; Freedman AS; Fisher DC; Slaughenhoupt B; Schlossman SF; Nadler LM
J Immunol; 1985 Mar; 134(3):1516-23. PubMed ID: 3871451
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD
J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731
[TBL] [Abstract][Full Text] [Related]
12. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
Maruyama S; Kubagawa H; Cooper MD
J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody.
Suzuki T; Cooper MD
J Immunol; 1985 May; 134(5):3111-9. PubMed ID: 2580014
[TBL] [Abstract][Full Text] [Related]
14. Cell surface phenotype of lymphoid cells from normal mice and mice treated with monoclonal anti-IgD from birth.
Skelly RR; Baine Y; Ahmed A; Xue B; Thorbecke GJ
J Immunol; 1983 Jan; 130(1):15-8. PubMed ID: 6600173
[TBL] [Abstract][Full Text] [Related]
15. Polyclonal activation of the murine immune system by an antibody to IgD. XI. Contribution of membrane IgD cross-linking to the generation of an in vivo polyclonal antibody response.
Goroff DK; Holmes JM; Bazin H; Nisol F; Finkelman FD
J Immunol; 1991 Jan; 146(1):18-25. PubMed ID: 1984444
[TBL] [Abstract][Full Text] [Related]
16. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
17. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
Sherris D; Stohl W; Mayer L
J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
[TBL] [Abstract][Full Text] [Related]
18. Cross-linking of surface IgM, but not surface IgD receptors, by soluble monoclonal antibodies primes murine B cells to secrete immunoglobulin in response to lymphokines.
Phillips C; Klaus GG
Eur J Immunol; 1993 Feb; 23(2):574-7. PubMed ID: 8436190
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).
Ledbetter JA; Shu G; Gallagher M; Clark EA
J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534
[TBL] [Abstract][Full Text] [Related]
20. Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140.
Pezzutto A; Dörken B; Moldenhauer G; Clark EA
J Immunol; 1987 Jan; 138(1):98-103. PubMed ID: 3097151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
